[1] 范慧洁, 戴如春, 廖二元. OPG/RANK/RANKL系统与骨折和类风湿性关节炎[J]. 国际内分泌代谢杂志, 2006, 26(4):241-244.
FAN H J, DAI R C, LIAO E Y. OPG/RANK/RANKL system in fracture and rheumatoid arthritis[J]. International Journal of Endocrinology and Metabolism, 2006, 26(4):241-244. (in Chinese)
[2] 付应霄, 顾建红, 赵鸿雁, 等. 骨保护素对破骨细胞活性的影响[J]. 中国兽医学报, 2013, 33(5):738-741.
FU Y X, GU J H, ZHAO H Y, et al. The effects of osteoprotegerin on the activity of osteoclasts[J]. Chinese Journal of Veterinary Science, 2013, 33(5):738-741. (in Chinese)
[3] DESELM C J, MILLER B C, WEI Z, et al. Autophagy proteins regulate the secretory component of osteoclastic bone resorption[J]. Dev Cell, 2011, 21(5):966-974.
[4] ZHAO H Y, LIU X Z, ZOU H, et al. Osteoprotegerin disrupts peripheral adhesive structures of osteoclasts by modulating Pyk2 and Src activities[J]. Cell Adh Migr, 2015, 10(3):299-309.
[5] 童琳, 余秀琼. 骨保护素的临床研究进展[J]. 心血管病学进展, 2013, 34(1):150-153.
TONG L, YU X Q. Progress in research of osteoprotegerin[J]. Advances in Cardiovascular Diseases, 2013, 34(1):150-153. (in Chinese)
[6] NYAMBO R, CROSS N, LIPPITT J, et al. Human bone marrow stromal cells protect prostate cancer cells from TRAIL-induced apoptosis[J]. J Bone Miner Res, 2004, 19(10):1712-1721.
[7] MAIURI M C, ZALCKVAR E, KIMCHI A, et al. Self-eating and self-killing:crosstalk between autophagy and apoptosis[J]. Nat Rev Mol Cell Biol, 2007, 8(9):741-752.
[8] 喻琴琴, 杨俊, 李馨欣. 自噬及其抑制剂的研究进展[J]. 实用医学杂志, 2013, 29(17):2908-2910.
YU Q Q, YANG J, LI X X. Advance research on autophagy and its inhibitor[J]. The Journal of Practical Medicine, 2013, 29(17):2908-2910. (in Chinese)
[9] LEVINE B, KROEMER G. Autophagy in the pathogenesis of disease[J]. Cell, 2008, 132(1):27-42.
[10] BAUD'HUIN M, LAMOUREUX F, DUPLOMB L, et al. RANKL, RANK, osteoprotegerin:key partners of osteoimmunology and vascular diseases[J]. Cell Mol Life Sci, 2007, 64(18):2334-2350.
[11] 孙自强. AKT/mTOR/ULK1介导的自噬在骨保护素调控破骨细胞骨吸收活性中的作用机制[D]. 扬州:扬州大学, 2017.
SUN Z Q. The role of autophagy in the regulation of osteoclast resorption by osteoprotegerin via AKT/mTOR/ULK1 signaling pathway[D]. Yangzhou:Yangzhou University, 2017. (in Chinese)
[12] 付应霄. OPG对破骨细胞活性的影响及其信号转导机制[D]. 扬州:扬州大学, 2013.
FU Y X. Influences of osteoprotegerin on the differentiation, activation, and survival of osteoclast and the involved signalling pathways[D]. Yangzhou:Yangzhou University, 2013. (in Chinese)
[13] 唐琪, 布文奂, 王丹丹, 等. 自噬与凋亡的相互作用及其对肿瘤发展过程影响的研究进展[J]. 吉林大学学报:医学版, 2015, 41(6):1303-1306.
TANG Q, BU W H, WANG D D, et al. Advance research on interaction between autophagy and apoptosis and its influence in development of tumors[J]. Journal of Jilin University:Medicine Edition, 2015, 41(6):1303-1306. (in Chinese)
[14] KIM M S, DAY C J, SELINGER C I, et al. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFκB ligand for bone resorption[J]. J Biol Chem, 2006, 281(2):1274-1285.
[15] KIMURA S, FUJITA N, NODA T, et al. Monitoring autophagy in mammalian cultured cells through the dynamics of LC3[J]. Methods Enzymol, 2009, 452:1-12.
[16] 李荣虎, 于论, 缪珀, 等. 缺氧缺血海马组织中自噬相关蛋白Beclin-1和LC3的表达变化以及雷帕霉素对其表达的影响[J]. 中国当代儿科杂志, 2015, 17(4):400-404.
LI R H, YU L, MIAO P, et al. Changes in expression of autophagy-related proteins, Beclin-1 and LC3, and effects of rapamycin on their expression in hypoxic-ischemic hippocampus[J]. Chinese Journal of Contemporary Pediatrics, 2015, 17(4):400-404. (in Chinese)
[17] BRUZZANITI A, BARON R. Molecular regulation of osteoclast activity[J]. Rev Endocr Metab Dis, 2006, 7(1-2):123-139.
[18] FLECHNER S M, GOLDFARB D, MODLIN C, et al. Kidney transplantation without calcineurin inhibitor drugs:a prospective, randomized trial of sirolimus versus cyclosporine[J]. Transplantation, 2002, 74(8):1070-1076.
[19] ALVAREZ-GARCIA O, CARBAJO-PÉREZ E, GARCIA E, et al. Rapamycin retards growth and causes marked alterations in the growth plate of young rats[J]. Pediatr Nephrol, 2007, 22(7):954-961.
[20] SUGATANI T, ALVAREZ U M, HRUSKA K A. Activin A stimulates IκB-α/NFκB and RANK expression for osteoclast differentiation, but not AKT survival pathway in osteoclast precursors[J]. J Cell Biochem, 2003, 90(1):59-67.
[21] SUGATANI T, HRUSKA K A. Akt1/Akt2 and mammalian target of rapamycin/bim play critical roles in osteoclast differentiation and survival, respectively, whereas Akt is dispensable for cell survival in isolated osteoclast precursors[J]. J Biol Chem, 2005, 280(5):3583-3589.
[22] XIU Y, XU H, ZHAO C, et al. Chloroquine reduces osteoclastogenesis in murine osteoporosis by preventing TRAF3 degradation[J]. J Clin Invest, 2014, 124(1):297-310.
[23] ZHAO H Y, GU J H, DAI N N, et al. Osteoprotegerin exposure at different stages of osteoclastogenesis differentially affects osteoclast formation and function[J]. Cytotechnology, 2016, 68(4):1325-1335.
[24] 王亚军. 玉米赤霉烯酮诱导大鼠Leydig细胞凋亡及自噬保护作用[D]. 扬州:扬州大学, 2014.
WANG Y J. Zearalenone induces apoptosis and cytoprotective autophagy in primary Leydig cells[D]. Yangzhou:Yangzhou University, 2014. (in Chinese)
[25] SONG R L, LIU X Z, ZHU J Q, et al. RhoV mediates apoptosis of RAW264. 7 macrophages caused by osteoclast differentiation[J]. Mol Med Rep, 2015, 11(2):1153-1159.
[26] 杨轩, 袁栋栋, 姜学军, 等. 顺铂通过诱导膀胱癌细胞自噬促进细胞凋亡[J]. 北京大学学报:医学版, 2013, 45(2):221-226.
YANG X, YUAN D D, JIANG X J, et al. Cisplatin enhances apoptosis in bladder cancer cells via autophagy[J]. Journal of Peking University:Health Sciences, 2013, 45(2):221-226. (in Chinese)
[27] WU C C, HUANG Y F, HSIEH C P, et al. Combined use of zoledronic acid augments ursolic acid-induced apoptosis in human osteosarcoma cells through enhanced oxidative stress and autophagy[J]. Molecules, 2016, 21(12):1640.
[28] 朱文胤, 陈倩倩, 刘祁, 等. 饥饿诱导下小鼠成骨细胞自噬与凋亡相互作用研究[J]. 川北医学院学报, 2015, 30(2):206-211.
ZHU W Y, CHEN Q Q, LIU Q, et al. Study on the interaction between autophagy and apoptosis of MC3 T3-E1 at starvation state[J]. Journal of North Sichuan Medical College, 2015, 30(2):206-211. (in Chinese) |